Peter Philip Gray AO FRSN FTSE (born in Sydney in 1946) is an Australian bioengineer who has played a key role in the development of modern industrial biotechnology in Australia.
He completed his PhD at the University of New South Wales (UNSW) in 1970, studying the dynamics of protein synthesis in yeast growing in steady state continuous cultures.
Cetus was one of the first biotechnology companies developing products based on recombinant DNA technology, and pioneering the use of mammalian cell culture to express large complex biologics such as antibodies.
He is Chair of the ATSE Steering Committee pushing for the introduction of a ‘Knowledge Transfer Metric’ to stimulate increased public/private research collaboration in Australia.
Gray is an active researcher who has published and patented widely in the fields of bioengineering, the production of biopharmaceuticals and stem cell technology.
[15] At the announcement attended by former Queensland Premier Anna Bligh, Professor Gray said, "The collaboration with DSMB will ensure that Australian bioresearchers will be able to rapidly progress their therapeutic leads into high purity material ready for evaluation in the clinic.
"[16] Gray has also helped to manufacture an antibody against Hendra virus on licence from the Henry Jackson Foundation, Uniformed Services University.